236 related articles for article (PubMed ID: 26233486)
1. Variations in opioid receptor genes in neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Sherva R; Brown MS; Davis JM; Farrer LA; Nielsen DA
Drug Alcohol Depend; 2015 Oct; 155():253-9. PubMed ID: 26233486
[TBL] [Abstract][Full Text] [Related]
2. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.
Wachman EM; Hayes MJ; Sherva R; Brown MS; Shrestha H; Logan BA; Heller NA; Nielsen DA; Farrer LA
Am J Addict; 2017 Jan; 26(1):42-49. PubMed ID: 27983768
[TBL] [Abstract][Full Text] [Related]
3. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Brown MS; Paul J; Harvey-Wilkes K; Terrin N; Huggins GS; Aranda JV; Davis JM
JAMA; 2013 May; 309(17):1821-7. PubMed ID: 23632726
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads.
Wachman EM; Hayes MJ; Shrestha H; Nikita FNU; Nolin A; Hoyo L; Daigle K; Jones HE; Nielsen DA
Genes Brain Behav; 2018 Sep; 17(7):e12476. PubMed ID: 29575474
[TBL] [Abstract][Full Text] [Related]
5. The genetics and epigenetics of Neonatal Abstinence Syndrome.
Wachman EM; Farrer LA
Semin Fetal Neonatal Med; 2019 Apr; 24(2):105-110. PubMed ID: 30709700
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Lester BM; Terrin N; Brown MS; Nielsen DA; Davis JM
J Pediatr; 2014 Sep; 165(3):472-8. PubMed ID: 24996986
[TBL] [Abstract][Full Text] [Related]
7. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
8. An analysis of genetic association in opioid dependence susceptibility.
Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic predictors of neonatal abstinence syndrome: correlation with length of stay.
Kelly LE; Knoppert D; Koren G
Ther Drug Monit; 2015 Jun; 37(3):281-2. PubMed ID: 25970505
[No Abstract] [Full Text] [Related]
10. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
11. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
Ho KWD; Wallace MR; Staud R; Fillingim RB
Pharmacogenomics J; 2020 Jun; 20(3):471-481. PubMed ID: 31806881
[TBL] [Abstract][Full Text] [Related]
12. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
13. Association Between Genetic Polymorphisms and Pain Sensitivity in Patients with Hip Osteoarthritis.
Olesen AE; Nielsen LM; Feddersen S; Erlenwein J; Petzke F; Przemeck M; Christrup LL; Drewes AM
Pain Pract; 2018 Jun; 18(5):587-596. PubMed ID: 29055075
[TBL] [Abstract][Full Text] [Related]
14. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
15. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS
Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
Gao X; Wang Y; Lang M; Yuan L; Reece AS; Wang W
OMICS; 2017 Jul; 21(7):404-412. PubMed ID: 28692418
[TBL] [Abstract][Full Text] [Related]
17. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
Mactier H; McLaughlin P; Gillis C; Osselton MD
Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
[No Abstract] [Full Text] [Related]
18. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
Jones JD; Luba RR; Vogelman JL; Comer SD
Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
[TBL] [Abstract][Full Text] [Related]
19. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
Zhang Q; Shi M; Tang H; Zhong H; Lu X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
[No Abstract] [Full Text] [Related]
20. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
